Events
Start of main content
Stem cells and organoids. Unlocking their potential to understand and treat disease
Life and Matter Sciences Series of Conferences February 8, 2018 Madrid
"Conference Cycle and Science Meeting"
General information
Venue: Fundación Ramón Areces, C/ Vitruvio, 5. 28006. Madrid
Limited capacity
- Simultaneous interpretation
- Free registration
Organized by:
Fundación Ramón Areces
In cooperation with:
Springer Nature
- Description
- Programme
The development, now more than 10 years ago, of genetic strategies that allow 'reprogramming' of adult cells to pluripotent stem cells brought to the biomedicine arena new means to study and treat diseases. This technology allows for the development of cellular models of disease by using human cells derived directly from patients, which allows the advancement of both basic disease knowledge and the development of specific therapies.
Reprogrammed cells also have the potential to be used as cell therapy and they are being investigated for diseases such as Parkinson's or immune diseases. In recent years, stem cell culture techniques (embryonic, adult or reprogrammed) have been refined to allow for the development of structures that resemble organs in vitro. Nowadays, 'organoids' similar to the human intestine, heart, eye, or brain have been developed and are currently allowing the study of both the basic processes involved in the development of these organs and the dysfunctions associated with developmental diseases.
Thursday, 8
17:30
Presentation
Raimundo Pérez-Hernández y Torra
Director of Fundación Ramón Areces.
Federico Mayor Zaragoza
Chairman of the Scientific Council of Fundación Ramón Areces.
Soledad Santos Suárez
Editorial Director Spain and Portugal, Springer Healthcare, a Springer Nature business.
17:45
Introduction
Erika Pastrana
Executive Editor for Nature Research, New York, USA.
Conferences
18:00
Adult liver and pancreas organoids and stem cells: Present and future of their biomedical utility
Meritxell Huch
Wellcome Trust/Cancer Research UK Gurdon Institute, Universidad de Cambridge, Cambridge, Reino Unido.
18:20
Using brain organoids to understand neurological diseases
Guo-Li Ming
Department of Neuroscience, Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, USA.
18:40
Therapeutic implications of Cancer Stem Cells
Cédric Blanpain
WELBIO, Laboratory of Stem Cells and Cancer, Université Libre de Bruxelles, Belgium.
19:00
Senescence and reprogramming: an integrated view of tissue repair
Manuel Serrano
Cellular Plasticity and Disease Group. Institute for Research in Biomedicine (IRB), Barcelona, España.
19:20
Discussion
Moderator:
Erika Pastrana
Round table
Meritxell Huch, Guo-Li Ming,Cédric Blanpain and Manuel Serrano
-
Activities related
-
Projects related
-
News related
-
Publications related
-
16
Feb
2023
Ciclo de conferencias y debates en ciencias Cellular therapies: New oportunities offered by genetic engineering and immunotherapy Madrid, Thursday, 16 February 2023, 17:30 hours
-
7
Mar
2023
International Symposium Membrane-Less Organelles in Cell Life and Disease Sevilla, Tuesday and Wednesday, 7 and 8 March 2023, 10:15 hours
-
13
Feb
2025
17th edition. Cycle of conferences and debates in science Digital Twins: Technological Advances and Application Opportunities Madrid, Thursday, 13 February 2025, 17:30 hours
- Study of EBV, HHV-6A AND HHV-6B MICRO-RNAs in plasma isolated exosomes of patients with multiple sclerosis: correlation with activity and progression of disease 2016 Senior Researcher : Roberto Álvarez Lafuente Research Centre or Institution : Hospital Universitario Clínico San Carlos. Instituto de Investigación Sanitaria San Carlos (IdISSC). Madrid.
- Understanding the connection between ROS/RNS homeostasis and the circadian signalling network: beyond the genetic level 2020 Senior Researcher : María del Carmen Martí Ruiz Research Centre or Institution : Centro de Edafología y Biología Aplicada del Segura (CEBAS-CSIC)
- Nutritional formulae for docosahexaenoic acid (DHA) and arachidonic (AA) deficiency control in extreme premature infants 2020 Senior Researcher : Miguel Sáenz de Pipaón Marcos Research Centre or Institution : Fundación para la Investigación Biomédica. Hospital Universitario La Paz. Madrid.
End of main content